NCLifeSci Contract R&D Luncheon and Forum: The Path to Success - Concept to Commercialization

John Fogarty, director of marketing, Mispro 

Fogarty is director of marketing at Mispro, a national contract vivarium organization providing preclinical research infrastructure for biotechnology companies. Positioned at the intersection of drug development, life science real estate and research services, Mispro is part of the growing shift toward research-ready environments that expand access to preclinical capabilities. Fogarty has been an active advocate for operating models that enable biotechnology companies to generate defensible preclinical data and advance drug development in today's evolving funding environment. He received his bachelor's degree from Arizona State University and a  mini-MBA from Bentley University, and he has a certificate in organizational leadership from Harvard Extension School.                                                                                                                                                      

Chase Jenkins, vice president of project delivery, HIPP Design + Consulting

Jenkins leads project execution with a focus on excellence, client satisfaction and sustainability. He has extensive experience in the design and renovation of cGMP manufacturing facilities, semiconductor-manufacturing plants and heavy industrial facilities. Currently, he is spearheading HIPP’s involvement in the Novo Nordisk Fill and Finish project. Jenkins oversees project design teams from conceptual development and scoping through detailed design and construction support to ensure scope, schedule and budget remain on target. As the primary client liaison for his projects, Jenkins fosters strong relationships and delivers high-quality results tailored to client needs. He holds a B.S. in mechanical engineering from North Carolina State University. 

Mark Leney, Ph.D., senior biopharmaceutical scientist, Uniphar

Leney advises biotechnology companies on regulatory strategy, CMC development, translational planning and commercialization readiness. With more than 25 years of experience across the US, Europe and Asia, he has supported organizations from venture-backed startups to global biopharma companies, spanning discovery through commercial manufacturing. Leney helps clients navigate regulatory interactions, manufacturing strategy, quality systems, due diligence and product development from early research through marketing authorization. His work translates scientific and commercial objectives into practical plans that reduce risk and accelerate execution. Leney holds a B.S. from the University of Edinburgh and a Ph.D. from the University of Cambridge.

Donna Parker, operations director, i-Cubed, Duke Clinical Research Institute

Parker works alongside the i-Cubed leadership team to design and implement the innovation center's structured approach for helping innovators transform their ideas from early concepts to market-ready strategies. She has led clinical research operations teams at the University of North Carolina and Duke in a multitude of therapeutic areas.  Parker enjoys bringing teams together to form, storm, norm and perform work that makes a difference in the world. She earned her master's degree in public health at the University of North Carolina-Chapel Hill.